Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Coherus BioSciences reports topline results for phase III study of CHS-1420

Aug. 9, 2016

Daiichi Sankyo discloses RORgammat antagonists

Aug. 4, 2016

Almirall and Patagonia Pharmaceuticals enter licensing agreement

July 25, 2016

Novan begins dosing in phase II SB-208 study

July 22, 2016

RepliCel Life Sciences product cleared for clinical research in Japan

July 22, 2016

BiopharmX reports PK data for BPX-01

July 22, 2016

Maruho and Galderma Pharma update progress made under strategic alliance

July 21, 2016

Chugai and Galderma sign license agreement for nemolizumab

July 21, 2016

FDA advisory committee votes to recommend brodalumab for moderate to severe plaque psoriasis

July 20, 2016

Clinuvel updates U.S. regulatory progress for Scenesse

July 18, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...